OLAPLEX Reports Third Quarter 2024 Results

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the third quarter and nine months ended Septemberย 30, 2024.

Amanda Baldwin, OLAPLEXโ€™s Chief Executive Officer, commented: "This year has been dedicated to transformation and we continue to make strides on our plan to prioritize product innovation and the Professional community. While we have seen meaningful progress against our strategic goals, we have revised our outlook for fiscal year 2024 as the trajectory of our transformation has shifted, with a particular focus on the realignment of our international business. We continue to focus on initiatives aimed at building a healthier business, including new sales and marketing investments, and now with a best-in-class executive team at the helm. OLAPLEX remains an incredibly powerful brand, and we are more confident than ever in delivering consistent and sustained growth."

For the third quarter of 2024 compared to the third quarter of 2023:

  • Net sales decreased 3.6% to $119.1 million;
    • By channel:
      • Professional decreased 12.6% to $42.2 million;
      • Direct-To-Consumer increased 6.8% to $34.3 million;
      • Specialty Retail decreased 1.3% to $42.6 million;
    • Net sales decreased 3.3% in the United States and decreased 3.9% internationally;
  • Net income decreased 27.3% and adjusted net income decreased 13.8%;
  • Diluted EPS was $0.02 for the third quarter of 2024, as compared to $0.03 for the third quarter of 2023; and
  • Adjusted Diluted EPS was $0.04 for the third quarter of 2024, as compared to $0.05 for the third quarter of 2023.

Three Months Ended Septemberย 30, 2024 Results

(Dollars in $000โ€™s, except per share and share data)ย ย ย ย ย ย 
ย ย Three Months Ended September 30,ย ย 
ย ย ย 2024ย ย ย 2023ย ย % Change
Net Salesย $119,080ย ย $123,555ย ย (3.6)%
Gross Profitย $81,734ย ย $83,548ย ย (2.2)
Gross Profit Marginย ย 68.6%ย ย 67.6%ย ย 
Adjusted Gross Profitย $84,299ย ย $86,140ย ย (2.1)
Adjusted Gross Profit Marginย ย 70.8%ย ย 69.7%ย ย 
SG&Aย $42,956ย ย $36,433ย ย 17.9
Adjusted SG&Aย $40,440ย ย $33,744ย ย 19.8
Net Incomeย $14,797ย ย $20,366ย ย (27.3)
Adjusted Net Incomeย $28,736ย ย $33,354ย ย (13.8)
Adjusted EBITDAย $44,638ย ย $51,540ย ย (13.4)
Adjusted EBITDA Marginย ย 37.5%ย ย 41.7%ย ย 
Diluted EPSย $0.02ย ย $0.03ย ย (33.3)
Adjusted Diluted EPSย $0.04ย ย $0.05ย ย (20.0)%
Weighted Average Diluted Shares Outstandingย ย 666,151,359ย ย ย 678,758,020ย ย ย 


Nine Months Ended Septemberย 30, 2024 Results

(Dollars in $000โ€™s, except per share and share data)ย ย ย ย ย ย 
ย ย Nine Months Ended September 30,ย ย 
ย ย ย 2024ย ย ย 2023ย ย % Change
Net Salesย $321,929ย ย $346,583ย ย (7.1)%
Gross Profitย $225,514ย ย $241,854ย ย (6.8)
Gross Profit Marginย ย 70.1%ย ย 69.8%ย ย 
Adjusted Gross Profitย $232,568ย ย $248,176ย ย (6.3)
Adjusted Gross Profit Marginย ย 72.2%ย ย 71.6%ย ย 
SG&Aย $128,816ย ย $119,770ย ย 7.6
Adjusted SG&Aย $120,244ย ย $108,924ย ย 10.4
Net Incomeย $28,322ย ย $47,486ย ย (40.4)
Adjusted Net Incomeย $68,083ย ย $85,975ย ย (20.8)
Adjusted EBITDAย $112,176ย ย $138,267ย ย (18.9)
Adjusted EBITDA Marginย ย 34.8%ย ย 39.9%ย ย 
Diluted EPSย $0.04ย ย $0.07ย ย (42.9)
Adjusted Diluted EPSย $0.10ย ย $0.13ย ย (23.1)%
Weighted Average Diluted Shares Outstandingย ย 664,723,301ย ย ย 681,089,543ย ย ย 


Adjusted gross profit, adjusted gross profit margin, adjusted SG&A, adjusted net income, adjusted EBITDA, adjusted EBITDA margin, and adjusted diluted EPS are measures that are not calculated or presented in accordance with generally accepted accounting principles in the United States ("GAAP"). For more information about how we use these non-GAAP financial measures in our business, the limitations of these measures, and a reconciliation of these measures to the most directly comparable GAAP measures, please see "Disclosure Regarding Non-GAAP Financial Measures" and the reconciliation tables that accompany this release.

Balance Sheet

As of Septemberย 30, 2024, the Company had $538.8 million of cash and cash equivalents, compared to $466.4 million as of Decemberย 31, 2023. Inventory at the end of the third quarter of 2024 was $85.9 million, compared to $95.9 million at Decemberย 31, 2023. Long-term debt, net of current portion and deferred debt issuance costs was $645.0 million as of Septemberย 30, 2024, compared to $649.0 million as of Decemberย 31, 2023.

Fiscal Year 2024 Guidance

The Company updated its guidance for net sales, adjusted net income and adjusted EBITDA for fiscal year 2024, as set forth below.

(Dollars in millions)Prior Fiscal Year 2024 GuidanceUpdated Fiscal Year 2024 Guidance
Net Sales$435-$463$405-$415
Adjusted Net Income*$87-$100$67-$73
Adjusted EBITDA*$143-$159$121-$127


The fiscal year 2024 net sales, adjusted net income and adjusted EBITDA guidance are approximations and are based on the Companyโ€™s plans and assumptions for the relevant period, including, but not limited to, the following:

  • Net Sales:
    • The Company's updated net sales guidance reflects three primary factors:
      • First, the Company anticipates weaker performance from its international business resulting from the Company's actions to simplify and further realign its distribution network in an effort to strengthen its international sales operations, as well as the Company's limited approach to international marketing that is expected to lead to softer demand.
      • Second, while the Company believes that sell-through on an absolute dollar basis at U.S. key accounts is largely consistent with trends throughout the year, the business is not yet experiencing the level of lift in demand from the deployment of new sales and marketing investments that the Company previously anticipated.
      • Third, the Company anticipates increased promotional activity during the holiday period across geographies relative to its previous assumption.
  • Adjusted Gross Profit Margin:
    • The Company anticipates adjusted gross profit margin* in the range of 70.9% to 71.6% compared to its prior assumption of 72.5% to 73.1% in fiscal year 2024.
    • The Company expects that adjusted gross profit margin will be lower than previously anticipated primarily due to greater deleverage from lower sales volumes on its fixed warehousing costs, as well as additional promotional activity expected during the fourth quarter of 2024.
  • Adjusted SG&A:
    • The Company expects adjusted SG&A* in the range of $167 million to $170 million in fiscal year 2024 compared to its prior assumption of $172 million to $179 million.
    • The Company anticipates that adjusted SG&A will be lower than previously expected primarily due to a reduction in fiscal year 2024 non-payroll-related advertising and marketing expenses compared to its previous assumption.
  • Adjusted EBITDA Margin:
    • The Company now expects adjusted EBITDA margin* in the range of 29.9% to 30.6% for fiscal year 2024, compared to prior assumption of 32.8% to 34.3%.
    • The Company now expects more adjusted EBITDA margin deleverage as compared to the prior fiscal year 2024 assumption due to its lower net sales forecast against expectations for continued investment in operating expenses.
  • Net Interest Expense:
    • The Company now expects net interest expense to be approximately $34 million during fiscal year 2024, compared to its previous assumption of $32 million to $34 million.
  • Adjusted Effective Tax Rate:
    • The Company now expects an adjusted effective tax rate* of approximately 19.5% for fiscal year 2024, compared to its previous assumption of 19.5% to 20.5%.

*Adjusted net income, adjusted EBITDA, adjusted gross profit margin, adjusted SG&A, adjusted EBITDA margin and adjusted effective tax rate are non-GAAP financial measures. See โ€œDisclosure Regarding Non-GAAP Financial Measuresโ€ for additional information.

Webcast and Conference Call Information

The Company plans to host an investor conference call and webcast to review third quarter 2024 financial results at 9:00am ET/6:00am PT on Novemberย 7, 2024. The webcast can be accessed at https://ir.olaplex.com. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days.

About OLAPLEX

OLAPLEX is an innovative, science-enabled, technology-driven beauty company with a mission to improve the hair health of its consumers. In 2014, OLAPLEX disrupted and revolutionized the prestige hair care category by creating innovative bond-building technology, which works by protecting, strengthening and relinking broken bonds in the hair during and after hair services. The brandโ€™s proprietary, patent-protected ingredients work on a molecular level to protect and repair damaged hair. OLAPLEXโ€™s award-winning products are sold through an expanding omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain forward-looking statements and information relating to the Company that are based on the beliefs of management as well as assumptions made by, and information currently available to, the Company. These forward-looking statements include, but are not limited to, statements about: the Companyโ€™s financial position, operating results, growth, sales and profitability; the Company's financial guidance for fiscal year 2024, including net sales, adjusted net income, adjusted EBITDA, adjusted gross profit margin, adjusted SG&A, adjusted EBITDA margin, net interest expense, adjusted effective tax rate and non-payroll related marketing and advertising expenses; demand for the Companyโ€™s products; the Companyโ€™s product development pipeline and the impact of new product introductions, including the timing thereof; the Company's U.S. and international distribution operations; the Companyโ€™s business plans, strategies, investments, priorities and objectives, including the impact and timing thereof; anticipated product costs and organizational costs; the Companyโ€™s sales, marketing and education initiatives, including promotions, and related investments, and the impact, focus and timing thereof; general economic trends and industry trends; the Company's executive leadership changes; inventory levels; seasonality; and other statements contained in this press release that are not historical or current facts. When used in this press release, words such as "may," "will," โ€œcould," "should," "intend," "potential," "continue," "anticipate," "believe," "estimate," "expect," "plan," "target," "predict," "project," "forecast," "seek" and similar expressions as they relate to the Company are intended to identify forward-looking statements.

The forward-looking statements in this press release reflect the Companyโ€™s current expectations and projections about future events and financial trends that management believes may affect the Companyโ€™s business, financial condition and results of operations. These statements are predictions based upon assumptions that may not prove to be accurate, and they are not guarantees of future performance. As such, you should not place significant reliance on the Companyโ€™s forward-looking statements. Neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements, including any such statements taken from third party industry and market reports.

Forward-looking statements involve known and unknown risks, inherent uncertainties and other factors that are difficult to predict which may cause the Companyโ€™s actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements, including, without limitation: competition in the beauty industry; the Companyโ€™s ability to effectively maintain and promote a positive brand image, expand its brand awareness and maintain consumer confidence in the quality, safety and efficacy of its products; the Companyโ€™s ability to anticipate and respond to market trends and changes in consumer preferences and execute on its growth strategies and expansion opportunities, including with respect to new product introductions; the Companyโ€™s ability to accurately forecast customer and consumer demand for its products; the Company's dependence on the success of its long-term strategic plan; the Companyโ€™s ability to limit the illegal distribution and sale by third parties of counterfeit versions of its products or the unauthorized diversion by third parties of its products; the Company's dependence on a limited number of customers for a large portion of its net sales; the Companyโ€™s ability to develop, manufacture and effectively and profitably market and sell future products; the Companyโ€™s ability to attract new customers and consumers and encourage consumer spending across its product portfolio; the Companyโ€™s ability to successfully implement new or additional marketing efforts; the Companyโ€™s relationships with and the performance of its suppliers, manufacturers, distributors and retailers and the Companyโ€™s ability to manage its supply chain; impacts on the Companyโ€™s business from political, regulatory, economic, trade and other risks associated with operating internationally; the Companyโ€™s ability to manage its executive leadership changes and to attract and retain senior management and other qualified personnel; the Companyโ€™s reliance on its and its third-party service providersโ€™ information technology; the Companyโ€™s ability to maintain the security of confidential information; the Companyโ€™s ability to establish and maintain intellectual property protection for its products, as well as the Companyโ€™s ability to operate its business without infringing, misappropriating or otherwise violating the intellectual property rights of others; the outcome of litigation and regulatory proceedings; the impact of changes in federal, state and international laws, regulations and administrative policy; the Companyโ€™s existing and any future indebtedness, including the Companyโ€™s ability to comply with affirmative and negative covenants under its credit agreement; the Companyโ€™s ability to service its existing indebtedness and obtain additional capital to finance operations and its growth opportunities; volatility of the Companyโ€™s stock price; the Companyโ€™s โ€œcontrolled companyโ€ status and the influence of investment funds affiliated with Advent International, L.P. over the Company; the impact of an economic downturn and inflationary pressures on the Companyโ€™s business; fluctuations in the Companyโ€™s quarterly results of operations; changes in the Companyโ€™s tax rates and the Companyโ€™s exposure to tax liability; and the other factors identified under the heading โ€œRisk Factorsโ€ in Companyโ€™s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") and in the other documents that the Company files with the SEC from time to time.

Many of these factors are macroeconomic in nature and are, therefore, beyond the Companyโ€™s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Companyโ€™s actual results, performance or achievements may vary materially from those described in this press release as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements in this press release represent managementโ€™s views as of the date hereof. Unless required by law, the Company neither intends nor assumes any obligation to update these forward-looking statements for any reason after the date hereof to conform these statements to actual results or to changes in the Companyโ€™s expectations or otherwise.

Disclosure Regarding Non-GAAP Financial Measures

In addition to the financial measures presented in this release in accordance with GAAP, the Company has included certain non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted effective tax rate, adjusted gross profit, adjusted gross profit margin, adjusted SG&A and adjusted basic and diluted EPS. Management believes these non-GAAP financial measures, when taken together with the Companyโ€™s financial results presented in accordance with GAAP, provide meaningful supplemental information regarding the Companyโ€™s operating performance and facilitate internal comparisons of its historical operating performance on a more consistent basis by excluding certain items that may not be indicative of its business, results of operations or outlook. In particular, management believes that the use of these non-GAAP measures may be helpful to investors as they are measures used by management in assessing the health of the Companyโ€™s business, determining incentive compensation and evaluating its operating performance, as well as for internal planning and forecasting purposes.

The Company calculates adjusted EBITDA as net income, adjusted to exclude: (1) interest expense, net; (2) income tax provision; (3) depreciation and amortization; (4) share-based compensation expense; (5) non-ordinary inventory adjustments; (6) non-ordinary costs and fees; (7) non-ordinary legal costs; and (8) Tax Receivable Agreement liability adjustments. The Company calculates adjusted EBITDA margin by dividing adjusted EBITDA by net sales. The Company calculates adjusted net income as net income, adjusted to exclude: (1) amortization of intangible assets (excluding software); (2) non-ordinary costs and fees; (3) non-ordinary legal costs; (4) non-ordinary inventory adjustments; (5) share-based compensation expense; (6) Tax Receivable Agreement liability adjustments; and (7) tax effect of non-GAAP adjustments. The Company calculates adjusted effective tax rate as effective income tax rate, adjusted to exclude the tax effect of non-GAAP adjustments referenced in item (7) of the immediately preceding sentence. The Company calculates adjusted gross profit as gross profit, adjusted to exclude: (1) non-ordinary inventory adjustments and (2) amortization of patented formulations. The Company calculates adjusted gross profit margin by dividing adjusted gross profit by net sales. The Company calculates adjusted SG&A as SG&A, adjusted to exclude: (1) share-based compensation expense; (2) non-ordinary legal costs; and (3) non-ordinary costs and fees. The Company calculates adjusted basic and diluted EPS as adjusted net income divided by weighted average basic and diluted shares outstanding, respectively. Please refer to "Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents" located in the financial supplement in this release for further information regarding these adjustments for the periods presented.

Please refer to "Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents" located in the financial supplement in this release for a reconciliation of these non-GAAP metrics to their most directly comparable financial measure stated in accordance with GAAP.

This release includes forward-looking guidance for adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted gross profit margin, adjusted effective tax rate and adjusted SG&A. The Company is not able to provide, without unreasonable effort, a reconciliation of the guidance for adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted gross profit margin, adjusted effective tax rate and adjusted SG&A to the most directly comparable GAAP measure because the Company does not currently have sufficient data to accurately estimate the variables and individual adjustments included in the most directly comparable GAAP measure that would be necessary for such reconciliations, including (a) income tax related accruals in respect of certain one-time items, (b) costs related to potential debt or equity transactions, and (c) other non-recurring expenses that cannot reasonably be estimated in advance. These adjustments are inherently variable and uncertain and depend on various factors that are beyond the Company's control and as a result it is also unable to predict their probable significance. Therefore, because management cannot estimate on a forward-looking basis without unreasonable effort the impact these variables and individual adjustments will have on its reported results in accordance with GAAP, it is unable to provide a reconciliation of the non-GAAP financial measures included in its fiscal year 2024 guidance.

ย 
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands, except per share and share data)
(Unaudited)
ย 
ย September 30, 2024ย December 31, 2023
Assetsย ย ย 
Current Assets:ย ย ย 
Cash and cash equivalents$538,829ย ย $466,400ย 
Accounts receivable, net of allowances of $21,309 and $21,465ย 34,886ย ย ย 40,921ย 
Inventoryย 85,907ย ย ย 95,922ย 
Other current assetsย 10,090ย ย ย 9,953ย 
Total current assetsย 669,712ย ย ย 613,196ย 
Property and equipment, netย 1,238ย ย ย 930ย 
Intangible assets, netย 911,477ย ย ย 947,714ย 
Goodwillย 168,300ย ย ย 168,300ย 
Other assetsย 8,430ย ย ย 10,198ย 
Total assets$1,759,157ย ย $1,740,338ย 
ย ย ย ย 
Liabilities and stockholdersโ€™ equityย ย ย 
Current Liabilities:ย ย ย 
Accounts payable$11,356ย ย $7,073ย 
Sales and income taxes payableย 5,654ย ย ย 9,067ย 
Accrued expenses and other current liabilitiesย 19,797ย ย ย 20,576ย 
Current portion of long-term debtย 6,750ย ย ย 6,750ย 
Current portion of Related Party payable pursuant to Tax Receivable Agreementย 13,006ย ย ย 12,675ย 
Total current liabilitiesย 56,563ย ย ย 56,141ย 
Long-term debtย 645,040ย ย ย 649,023ย 
Deferred tax liabilitiesย 3,636ย ย ย 3,016ย 
Related Party payable pursuant to Tax Receivable Agreementย 172,390ย ย ย 185,496ย 
Other liabilitiesย 1,798ย ย ย 1,694ย 
Total liabilitiesย 879,427ย ย ย 895,370ย 
ย ย ย ย 
Contingenciesย ย ย 
ย ย ย ย 
Stockholdersโ€™ equity:ย ย ย 
Common stock, $0.001 par value per share; 2,000,000,000 shares authorized, 662,479,324 and 660,731,935 shares issued and outstanding as of Septemberย 30, 2024 and Decemberย 31, 2023, respectivelyย 662ย ย ย 671ย 
Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstandingย โ€”ย ย ย โ€”ย 
Additional paid-in capitalย 325,288ย ย ย 316,489ย 
Accumulated other comprehensive (loss) incomeย (985)ย ย 1,365ย 
Retained earningsย 554,765ย ย ย 526,443ย 
Total stockholdersโ€™ equityย 879,730ย ย ย 844,968ย 
Total liabilities and stockholdersโ€™ equity$1,759,157ย ย $1,740,338ย 


ย 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(amounts in thousands, except per share and share data)
(Unaudited)
ย 
ย Three Months Ended
September 30,
ย Nine Months Ended
September 30,
ย ย 2024ย ย ย 2023ย ย ย 2024ย ย ย 2023ย 
Net sales$119,080ย ย $123,555ย ย $321,929ย ย $346,583ย 
Cost of sales:ย ย ย ย ย ย ย 
Cost of product (excluding amortization)ย 34,781ย ย ย 37,415ย ย ย 89,361ย ย ย 98,431ย 
Amortization of patented formulationsย 2,565ย ย ย 2,592ย ย ย 7,054ย ย ย 6,298ย 
Total cost of salesย 37,346ย ย ย 40,007ย ย ย 96,415ย ย ย 104,729ย 
Gross profitย 81,734ย ย ย 83,548ย ย ย 225,514ย ย ย 241,854ย 
Operating expenses:ย ย ย ย ย ย ย 
Selling, general, and administrativeย 42,956ย ย ย 36,433ย ย ย 128,816ย ย ย 119,770ย 
Amortization of other intangible assetsย 10,782ย ย ย 10,378ย ย ย 32,807ย ย ย 31,025ย 
Total operating expensesย 53,738ย ย ย 46,811ย ย ย 161,623ย ย ย 150,795ย 
Operating incomeย 27,996ย ย ย 36,737ย ย ย 63,891ย ย ย 91,059ย 
Interest expenseย (15,610)ย ย (14,692)ย ย (44,708)ย ย (43,283)
Interest incomeย 6,605ย ย ย 5,182ย ย ย 19,067ย ย ย 13,024ย 
Other income (expense), netย 670ย ย ย (970)ย ย (541)ย ย (1,328)
Income before provision for income taxesย 19,661ย ย ย 26,257ย ย ย 37,709ย ย ย 59,472ย 
Income tax provisionย 4,864ย ย ย 5,891ย ย ย 9,387ย ย ย 11,986ย 
Net income$14,797ย ย $20,366ย ย $28,322ย ย $47,486ย 
Net income per share:ย ย ย ย ย ย ย 
Basic$0.02ย ย $0.03ย ย $0.04ย ย $0.07ย 
Diluted$0.02ย ย $0.03ย ย $0.04ย ย $0.07ย 
Weighted average common shares outstanding:ย ย ย ย ย ย ย 
Basicย 662,248,231ย ย ย 654,702,392ย ย ย 661,586,351ย ย ย 653,603,665ย 
Dilutedย 666,151,359ย ย ย 678,758,020ย ย ย 664,723,301ย ย ย 681,089,543ย 
ย ย ย ย ย ย ย ย 
Other comprehensive (loss) income:ย ย ย ย ย ย ย 
Unrealized (loss) gain on derivatives, net of income tax effect$(906)ย $(861)ย $(2,350)ย $229ย 
Total other comprehensive (loss) incomeย (906)ย ย (861)ย ย (2,350)ย ย 229ย 
Comprehensive income$13,891ย ย $19,505ย ย $25,972ย ย $47,715ย 


ย 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(amounts in thousands)
(Unaudited)
ย 
ย Nine Months Ended
September 30,
ย ย 2024ย ย ย 2023ย 
Cash flows from operating activitiesย ย ย 
Net income$28,322ย ย $47,486ย 
Adjustments to reconcile net income to net cash provided by operating activitiesย 65,088ย ย ย 81,011ย 
Net cash provided by operating activitiesย 93,410ย ย ย 128,497ย 
Net cash used in investing activitiesย (3,369)ย ย (2,902)
Net cash used in financing activitiesย (17,612)ย ย (18,817)
Net increase in cash and cash equivalentsย 72,429ย ย ย 106,778ย 
Cash and cash equivalents - beginning of periodย 466,400ย ย ย 322,808ย 
Cash and cash equivalents - end of period$538,829ย ย $429,586ย 


Reconciliation of Non-GAAP Financial
Measures to GAAP Equivalents

(Unaudited)

The following tables present a reconciliation of net income, gross profit and SG&A, as the most directly comparable financial measure stated in accordance with U.S. GAAP, to adjusted EBITDA, adjusted EBITDA margin, adjusted gross profit, adjusted gross profit margin, adjusted SG&A, adjusted net income and adjusted net income per share for each of the periods presented.

ย Three Months Ended
September 30,
ย Nine Months Ended
September 30,
(in thousands)ย 2024ย ย ย 2023ย ย ย 2024ย ย ย 2023ย 
Reconciliation of Net Income to Adjusted EBITDAย ย ย ย ย ย ย 
Net income$14,797ย ย $20,366ย ย $28,322ย ย $47,486ย 
Depreciation and amortization of intangible assetsย 13,456ย ย ย 13,084ย ย ย 40,254ย ย ย 37,666ย 
Interest expense, netย 9,005ย ย ย 9,510ย ย ย 25,641ย ย ย 30,259ย 
Income tax provisionย 4,864ย ย ย 5,891ย ย ย 9,387ย ย ย 11,986ย 
Share-based compensationย 2,516ย ย ย 2,686ย ย ย 8,560ย ย ย 7,338ย 
One-time former distributor payment(1)ย โ€”ย ย ย โ€”ย ย ย โ€”ย ย ย 3,500ย 
Inventory write off and disposal(2)ย โ€”ย ย ย โ€”ย ย ย โ€”ย ย ย 24ย 
Executive reorganization cost(3)ย โ€”ย ย ย 3ย ย ย 12ย ย ย 8ย 
Adjusted EBITDA$44,638ย ย $51,540ย ย $112,176ย ย $138,267ย 
Adjusted EBITDA marginย 37.5%ย ย 41.7%ย ย 34.8%ย ย 39.9%


ย Three Months Ended
September 30,
ย Nine Months Ended
September 30,
(in thousands)ย 2024ย ย ย 2023ย ย ย 2024ย ย ย 2023ย 
Reconciliation of Gross Profit to Adjusted Gross Profitย ย ย ย ย ย ย 
Gross profit$81,734ย ย $83,548ย ย $225,514ย ย $241,854ย 
Amortization of patented formulationsย 2,565ย ย ย 2,592ย ย ย 7,054ย ย ย 6,298ย 
Inventory write off and disposal(2)ย โ€”ย ย ย โ€”ย ย ย โ€”ย ย ย 24ย 
Adjusted gross profit$84,299ย ย $86,140ย ย $232,568ย ย $248,176ย 
Adjusted gross profit marginย 70.8%ย ย 69.7%ย ย 72.2%ย ย 71.6%


ย ย Three Months Ended
September 30,
ย Nine Months Ended
September 30,
(in thousands)ย ย 2024ย ย ย 2023ย ย ย 2024ย ย ย 2023ย 
Reconciliation of SG&A to Adjusted SG&Aย ย ย ย ย ย ย ย 
SG&Aย $42,956ย ย $36,433ย ย $128,816ย ย $119,770ย 
Share-based compensationย ย (2,516)ย ย (2,686)ย ย (8,560)ย ย (7,338)
One-time former distributor payment(1)ย ย โ€”ย ย ย โ€”ย ย ย โ€”ย ย ย (3,500)
Executive reorganization cost(3)ย ย โ€”ย ย ย (3)ย ย (12)ย ย (8)
Adjusted SG&Aย $40,440ย ย $33,744ย ย $120,244ย ย $108,924ย 


ย Three Months Ended
September 30,
ย Nine Months Ended
September 30,
(in thousands, except per share data)ย 2024ย ย ย 2023ย ย ย 2024ย ย ย 2023ย 
Reconciliation of Net Income to Adjusted Net Incomeย ย ย ย ย ย ย 
Net income$14,797ย ย $20,366ย ย $28,322ย ย $47,486ย 
Amortization of intangible assets (excluding software)ย 12,748ย ย ย 12,770ย ย ย 37,602ย ย ย 36,845ย 
Share-based compensationย 2,516ย ย ย 2,686ย ย ย 8,560ย ย ย 7,338ย 
One-time former distributor payment(1)ย โ€”ย ย ย โ€”ย ย ย โ€”ย ย ย 3,500ย 
Inventory write off and disposal(2)ย โ€”ย ย ย โ€”ย ย ย โ€”ย ย ย 24ย 
Executive reorganization cost(3)ย โ€”ย ย ย 3ย ย ย 12ย ย ย 8ย 
Tax effect of adjustmentsย (1,325)ย ย (2,471)ย ย (6,413)ย ย (9,226)
Adjusted net income$28,736ย ย $33,354ย ย $68,083ย ย $85,975ย 
Adjusted net income per share:ย ย ย ย ย ย ย 
Basic$0.04ย ย $0.05ย ย $0.10ย ย $0.13ย 
Diluted$0.04ย ย $0.05ย ย $0.10ย ย $0.13ย 


(1)During the nine months ended September 30, 2023, the Company made a one-time $3.5 million payment to a former distributor in the United Arab Emirates, which enabled the Company to establish a partnership with another distributor in the region.
ย ย 
(2)The inventory write-off and disposal costs related to unused stock of a product that the Company reformulated in June 2021 as a result of regulation changes in the E.U. In the interest of having a single formulation for sale worldwide, the Company reformulated on a global basis and disposed the unused stock.
ย ย 
(3)Represents ongoing benefit payments associated with the departure of the Company's Chief Executive Officer that occurred in fiscal year 2023 and Chief Operating Officer that occurred in fiscal year 2022.
ย ย 

Contacts:
Investors:

Patrick Flaherty
Vice President, Investor Relations
patrick.flaherty@olaplex.com

Financial Media:

Lisa Bobroff
Vice President, Global Communications & Consumer Engagement
lisa.bobroff@olaplex.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.50
-4.32 (-1.87%)
AAPL  271.01
-0.85 (-0.31%)
AMD  223.47
+9.31 (4.35%)
BAC  55.95
+0.95 (1.73%)
GOOG  315.32
+1.52 (0.48%)
META  650.41
-9.68 (-1.47%)
MSFT  472.94
-10.68 (-2.21%)
NVDA  188.85
+2.35 (1.26%)
ORCL  195.71
+0.80 (0.41%)
TSLA  438.07
-11.65 (-2.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article